Pain News and Research

Latest Pain News and Research

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced results from PALACE 3, the Company's third phase III study in psoriatic arthritis (PsA), at EULAR, the European Congress of Rheumatology annual meeting in Madrid, Spain.

15 Jun 2013

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

The painful rheumatic condition gout is often associated with the big toe, but it turns out that patients at highest risk of further flare-ups are those whose gout first involved other joints, such as a knee or elbow, Mayo Clinic has found.

15 Jun 2013

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Opioids, such as morphine, are still the most effective class of painkillers, but they come with unwanted side effects and can also be addictive and deadly at high doses. Designing new pain-killing drugs of this type involves testing them on their corresponding receptors, but access to meaningful quantities of these receptors that can work in experimental conditions has always been a limiting factor.

15 Jun 2013

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick®, a single-dose epinephrine auto-injector, for the emergency treatment of life threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Adrenaclick® will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths.

15 Jun 2013

Lorry driver who developed PTSD after fatal collision receives £220,000

A lorry driver who developed post-traumatic stress disorder after being involved in a fatal collision has received £220,000 in an out of court settlement for his fatal accident claim.

15 Jun 2013

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

After three years of research, a multicenter, national research study led by Beaumont orthopedic surgeon and sports medicine specialist, Joseph Guettler, M.D., may have some answers as to why youth baseball pitching injuries continue to rise despite the implementation of nationally recommended pitching limits.

15 Jun 2013

Specialists working in migraine and headache share scientific advances at International Headache Congress

Researchers and clinicians worldwide working in migraine, headache and brain injury share the field's latest scientific advances at the International Headache Congress, hosted by the International Headache Society and the American Headache Society.

15 Jun 2013

State highlights: Ga. ponders higher health plan rates for employees

Home health care providers in Oregon and their allies say their industry is in a bind. The state's rural home health providers don't make as much as they should from serving Medicare patients, and the state's providers overall are slated for an even bigger hit next year, according to the industry's advocates and allies in Congress.

15 Jun 2013

Teva to present abstracts on AZILECT at MDS meeting

Teva Pharmaceutical Industries Ltd. announced today that a number of abstracts will be presented during the 17th Annual International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia, June 16-20, 2013, also known as the Movement Disorders Society.

15 Jun 2013

Lineage Therapeutics announces US launch of generic epinephrine auto-injector

Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick by Amedra Pharmaceuticals LLC, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.

15 Jun 2013

Hospitalized patients do not receive blood thinners to prevent blood clots, researchers report

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.

15 Jun 2013

Gulf War illness may have two distinct forms, study says

Researchers at Georgetown University Medical Center say their new work suggests that Gulf War illness may have two distinct forms depending on which brain regions have atrophied. Their study of Gulf War veterans, published online today in PLOS ONE, may help explain why clinicians have consistently encountered veterans with different symptoms and complaints.

15 Jun 2013

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

The first use of deep brain stimulation to the brain's so-called "feeding center" - the lateral hypothalamic area (LHA) - was associated with a weight loss trend in morbidly obese patients whose stimulation was tuned to increase metabolism with novel guidance from metabolic chamber data, according to a pilot study presented at the International Neuromodulation Society's 11th World Congress by Dr. Michael Oh of the Department of Neurosurgery at the Allegheny General Hospital in Pittsburgh, Pa.

14 Jun 2013

Society of Interventional Radiology adds 18 Fellows to its roster

The Society of Interventional Radiology (SIR) announced the addition of 18 Fellows to the Fairfax, Virginia-based, national organization's roster during SIR's 38th Annual Scientific Meeting, held April 13 in New Orleans.

14 Jun 2013

Emergency department doctors are not identifying pelvic inflammatory disease in adolescent girls

Despite government efforts to expand diagnostic criteria for pelvic inflammatory disease, emergency department doctors are not identifying the condition any more often in adolescent girls, finds a new study in Journal of Adolescent Health.

14 Jun 2013

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Celgene International Sàrl, a subsidiary of Celgene Corporation today presented results from a randomized, placebo-controlled phase II trial in patients with Behçet's disease at EULAR, the European Congress of Rheumatology annual meeting in Madrid.

14 Jun 2013

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.

14 Jun 2013

Pain News and Research

Latest Pain News and Research

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Lorry driver who developed PTSD after fatal collision receives £220,000

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

Specialists working in migraine and headache share scientific advances at International Headache Congress

State highlights: Ga. ponders higher health plan rates for employees

Teva to present abstracts on AZILECT at MDS meeting

Lineage Therapeutics announces US launch of generic epinephrine auto-injector

Hospitalized patients do not receive blood thinners to prevent blood clots, researchers report

Gulf War illness may have two distinct forms, study says

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

Society of Interventional Radiology adds 18 Fellows to its roster

Emergency department doctors are not identifying pelvic inflammatory disease in adolescent girls

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Ischaemic heart disease patients at risk after 1 week of treatment

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Data demonstrate benefits of nurse-led programme on patient self-management of RA

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in